Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism (Q77933829)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

U Tebbe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

A Graf

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

W Kamke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

R Zahn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

F Forycki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

G Kratzsch

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

G Berg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

English

0 references

publication date

1 July 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

1 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

39-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

Natural history of pulmonary embolism

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Fatal pulmonary emboli in hospitalized patients. An autopsy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Mortality from pulmonary embolism in the United States: 1962 to 1984

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Acute pulmonary embolism treated with tissue plasminogen activator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

A comparison of reteplase with alteplase for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Comparison of Streptokinase and Heparin in Treatment of Isolated Acute Massive Pulmonary Embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Hemodynamic effects of bolus vs 2-h infusion of alteplase in acute massive pulmonary embolism. A randomized controlled multicenter trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

Two trials of reduced bolus alteplase in the treatment of pulmonary embolism. An overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970243-7

10.1016/S0002-8703(99)70243-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385761%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference